Short Note
Version 1
This version is not peer-reviewed
DIPA-CRISPR Gene Editing: A Review Exploring New Horizons in Disease Management
Version 1
: Received: 14 July 2024 / Approved: 15 July 2024 / Online: 15 July 2024 (04:53:50 CEST)
How to cite: Shah, A.; Desai, D.; Shah, H. DIPA-CRISPR Gene Editing: A Review Exploring New Horizons in Disease Management. Preprints 2024, 2024071124. https://doi.org/10.20944/preprints202407.1124.v1 Shah, A.; Desai, D.; Shah, H. DIPA-CRISPR Gene Editing: A Review Exploring New Horizons in Disease Management. Preprints 2024, 2024071124. https://doi.org/10.20944/preprints202407.1124.v1
Abstract
DIPA-CRISPR is a revolutionary gene editing technology that has set new benchmarks in precision and efficacy. It builds upon the CRISPR-Cas9 system, introducing unparalleled specificity and minimizing unintended effects. Its potential applications in addressing complex genetic disorders offer hope for more effective disease management. The integration of DIPA-CRISPR into gene therapy research signifies a monumental leap forward in medical science and biotechnology. This article explores the DIPA-CRISPR methodology, its core principles, and recent technological strides in refining the technique. It highlights the implications of these developments on the treatment of genetic conditions and discusses future prospects and innovations within the field. The transformative potential of DIPA-CRISPR in disease management and the broader spectrum of genetic engineering is underscored, heralding a new age of medical and scientific discovery. The emphasis on addressing both technical and ethical challenges underscores the complexity and responsibility that accompanies such powerful technological advancements. The future prospects of DIPA-CRISPR, from pest management to combating global infectious diseases and transforming oncology, underscore the need for continued innovation coupled with rigorous ethical oversight.
Keywords
DIPA-CRISPR; Cockroach; insects; gene editing; Duchenne Muscular Dystrophy
Subject
Medicine and Pharmacology, Other
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
